DEPAKINE 200 mg/ml, oral solution bottle, 40 ml
Brand page: Depakine, Depakine Chrono (valproic acid (sodium valproate)) — all forms and strengths in France
Active ingredients: Sodium valproate
Commercialized according to BDPMDispensing in France: Prescription only
Oral solutionbottle, 40 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DEPAKINE 200 mg/ml, solution buvable
- Pharmaceutical form
- solution buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre brun de 40 ml avec mesurette graduée polyéthylène
- Marketing authorisation holder
- SANOFI WINTHROP INDUSTRIE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Jan 1967
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a specialist
- Prescribed by specialists only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
62410472CIP73029300CIP133400930293003Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| VALPROATE DE SODIUMsolution | 20,00 g · 100 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.